Punnee Pitisuttithum Selected Research

AIDSVAX B-E

3/2014	Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.
8/2012	Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.
7/2012	Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.
12/2009	Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
2/2009	Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
9/2004	Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Punnee Pitisuttithum Research Topics

Disease

38	Infections 11/2021 - 01/2004
13	HIV Infections (HIV Infection) 12/2018 - 07/2003
9	Acquired Immunodeficiency Syndrome (AIDS) 02/2015 - 10/2006
7	Dengue (Dengue Fever) 10/2018 - 01/2013
4	Human Influenza (Influenza) 01/2021 - 03/2013
3	COVID-19 03/2022 - 01/2021
3	Persistent Infection 11/2021 - 10/2014
3	Neoplasms (Cancer) 11/2021 - 01/2015
3	Whooping Cough (Pertussis) 07/2021 - 01/2018
3	Tetanus 07/2021 - 01/2018
3	Diphtheria 07/2021 - 01/2018
3	Fever (Fevers) 01/2021 - 01/2013
3	Communicable Diseases (Infectious Diseases) 10/2020 - 04/2008
3	Cryptococcal Meningitis 01/2017 - 09/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015 - 09/2009
3	Tuberculosis (Tuberculoses) 01/2014 - 11/2007
3	Opportunistic Infections (Opportunistic Infection) 11/2011 - 03/2005
2	Papillomavirus Infections 11/2021 - 01/2015
2	Breakthrough Infections 01/2021 - 02/2015
2	Virus Diseases (Viral Diseases) 01/2020 - 08/2015
2	Disease Progression 01/2020 - 12/2006
2	Malaria 10/2018 - 01/2013
2	Immune Reconstitution Inflammatory Syndrome 03/2013 - 01/2010
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2013 - 08/2005
2	Coinfection 05/2012 - 12/2006
2	Lipodystrophy 11/2011 - 03/2005
2	Invasive Fungal Infections 06/2006 - 10/2005
1	Atypical Squamous Cells of the Cervix 01/2022
1	Squamous Intraepithelial Lesions 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Influenza in Birds (Avian Flu) 01/2020
1	Back Pain (Backache) 01/2018
1	Dizziness (Lightheadedness) 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Vaccinia 01/2018
1	Eye Infections 10/2017
1	Blindness (Hysterical Blindness) 10/2017
1	Neonatal herpes 10/2017
1	Eye Diseases (Eye Disease) 10/2017
1	Herpes Labialis (Fever Blister) 10/2017
1	Dysentery 01/2016
1	Diarrhea 01/2016
1	Bacillary Dysentery (Shigellosis) 01/2016
1	Vaginal Diseases 02/2015
1	Anus Neoplasms (Anal Cancer) 01/2015
1	Condylomata Acuminata (Genital Wart) 01/2015

Drug/Important Bio-Agent (IBA)

48	VaccinesIBA 03/2022 - 07/2003
15	AntibodiesIBA 11/2021 - 04/2012
14	Immunoglobulin G (IgG)IBA 11/2021 - 04/2012
10	Immunoglobulin A (IgA)IBA 11/2020 - 04/2012
8	AIDS VaccinesIBA 10/2017 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2012
6	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 09/2009
6	AntigensIBA 10/2021 - 08/2005
6	AIDSVAX B-EIBA 03/2014 - 09/2004
5	Dengue VaccinesIBA 01/2018 - 10/2014
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 03/2013
4	AIDSVAXIBA 03/2014 - 12/2009
3	Neutralizing AntibodiesIBA 10/2021 - 01/2013
3	Pertussis ToxinIBA 07/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2005
3	Glycoproteins (Glycoprotein)IBA 10/2017 - 07/2003
3	nevirapine drug combination lamivudine stavudineIBA 11/2011 - 03/2005
2	Pertussis VaccineIBA 07/2021 - 01/2018
2	ToxoidsIBA 07/2021 - 11/2018
2	EpitopesIBA 11/2018 - 01/2013
2	Immunoglobulin M (IgM)IBA 01/2018 - 01/2013
2	Monoclonal AntibodiesIBA 10/2017 - 08/2015
2	aluminum sulfate (alum)IBA 02/2015 - 09/2004
2	Antiviral Agents (Antivirals)IBA 07/2014 - 04/2014
2	Nevirapine (Viramune)FDA Link 06/2007 - 09/2006
2	Fluconazole (Zonal)FDA LinkGeneric 10/2006 - 07/2002
2	posaconazole FDA Link 06/2006 - 10/2005
1	Polysaccharides (Glycans)IBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018
1	CD40 Ligand (CD40L)IBA 12/2018
1	Respiratory Syncytial Virus VaccinesIBA 10/2018
1	GP 140IBA 01/2018
1	Combined VaccinesIBA 01/2018
1	AluminumIBA 01/2018
1	CYD-TDV vaccineIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Virus ReceptorsIBA 10/2017
1	NectinsIBA 10/2017
1	A 17 (A-17)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Broadly Neutralizing AntibodiesIBA 12/2016
1	nanolucIBA 12/2016
1	Protein Isoforms (Isoforms)IBA 12/2016
1	MF59 oil emulsionIBA 02/2015
1	Aluminum Hydroxide (Algeldrate)FDA Link 02/2015
1	chironIBA 02/2015
1	HIV Envelope Protein gp120IBA 01/2015

Therapy/Procedure

4	Therapeutics 01/2017 - 10/2005
4	Art Therapy 03/2013 - 11/2007
2	Activities of Daily Living (ADL) 11/2012 - 04/2011
2	Highly Active Antiretroviral Therapy (HAART) 01/2010 - 05/2009